Product category:
Contract research
News Release from: Melbourn Scientific | Subject: Stability testing services
Edited by the Laboratorytalk Editorial
Team on 05 January 2007
Melbourn increases parenteral testing
capacity
Melbourn Scientific is one of the first UK contract laboratories to invest in a light obscuration particle counter, enabling it to size and accurately count sub-visible particles in liquid samples
This development, combined with light microscopy techniques and newly expanded and refurbished stability storage suite, further extends the company's capacity in stability testing of injectable solutions Recent expansion into an ergonomically-designed laboratory has enabled Melbourn to increase its capacity in specialist areas, as business development director Mark Hammond explains: "We have seen significant growth in demand for the analysis of parenterals and have increased capacity in this area by investing in additional facilities, equipment and people since we moved into the laboratory in August, and further expansion is planned
This article was originally published on Laboratorytalk on 24 Oct 2005 at 8.00am (UK)
Related stories
Clients offered on-line update
Contract research organisation Melbourn Scientific is to launch a unique on-line service offering its global client base up-to-the-minute details on the status of their respective projects.
Pharmacopoeial test facility expanded
It might look like something out of Harry Potter, but it is compulsory for all new products and there are fewer and fewer companies with the specialist skills needed to perform the tests
"Within the new facility we have the opportunity to create dedicated areas for the different procedures, giving clients access to specialist equipment as and when it is required".
The laser particle counter is designed to accurately sample liquids and is capable of measuring particulates in fluids with various refractive indexes, viscosities and operating temperatures.
Applications include quality control for consistency of particles and uniform suspension, the real time detection of contamination at user selected sizing sensitivities, which can be up to 15 different channels.
The sensitivity thresholds can be adjusted to aid characterisation of particle size and concentration.
Particle counting at Melbourn is carried out using a variety of techniques that are compliant with USP and PhEur pharmacopoeia for parenteral/injectable solutions, patches and bags.
In addition to the sub-visible particle counting using a light obscuration particle counter the company also uses light microscopy, for the visual assessment of particulates and precipitates, which gives the option for photographic recording of the findings.
The investment in the LiQuilaz equipment improves the accuracy and speed of analysis enabling Melbourn to increase its throughput and efficiency.
The precision of the counter means that short sampling intervals can be used without sacrificing statistical significance.
The sampled data is processed using a powerful software program, enabling an operator to collect, display, store and report in many different formats.
The Pharmaceutical Net program is very flexible for use as a simple monitoring tool or as an advanced analysis package.
• Melbourn Scientific: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
